Signpost Capital Advisors, LP - Q1 2016 holdings

$214 Million is the total value of Signpost Capital Advisors, LP's 25 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .

 Value Shares↓ Weighting
PFE NewPfizer Inc$9,033,000304,764
+100.0%
4.23%
ALNY NewAlnylam Pharmaceuticals Inc$2,157,00034,365
+100.0%
1.01%
NewPeabody Energy Corp$1,091,000470,400
+100.0%
0.51%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2016-07-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Amazon.com Inc8Q3 201614.7%
AMTRUST FINL SVCS INC8Q1 201512.9%
Endo Pharmaceuticals Holdings8Q4 201511.6%
Priceline Group Inc8Q1 20168.8%
The Medicines Co8Q1 20174.9%
CALPINE CORP7Q1 201730.4%
MONSANTO CO NEW7Q4 20148.1%
Liberty Global Plc7Q1 20163.1%
Esterline Technologies Corp6Q2 201514.7%
VALERO ENERGY CORP NEW6Q3 201412.6%

View Signpost Capital Advisors, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2017-05-01
13F-HR2017-02-13
13F-HR2016-11-10
13F-HR2016-08-12
13F-HR/A2016-07-13
13F-HR2016-05-13
13F-HR2016-02-12
13F-HR/A2015-11-13
13F-HR2015-11-13
13F-HR2015-08-14

View Signpost Capital Advisors, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (213758000.0 != 213755000.0)
  • The reported has been restated
  • The reported has been amended

Export Signpost Capital Advisors, LP's holdings